Retrospective Analysis of Direct-Acting Antiviral Treatment Outcomes in Hepatitis C Patients in Saudi Arabia Before and After Therapy - Takeaways - MDSpire

Retrospective Analysis of Direct-Acting Antiviral Treatment Outcomes in Hepatitis C Patients in Saudi Arabia Before and After Therapy

  • By

  • Fatimah Salem Alayidh

  • Alexander Woodman

  • Nawaf Yahya Zakary

  • Rehab Yusuf Al-Ansari

  • Sharjeel Chaudhry

  • Amal Omar Alsaadi

  • Khadijah Ahmad Alharbi

  • Batool Abdullah Alamri

  • Shahad Mousa Alhomud

  • Shahad Hassan Albather

  • Sarah Abdullah Bataweel

  • Nouf Ahmed Madkhali

  • Samira Jamaan Alzahrani

  • Zarmina Ehtesham

  • February 2, 2026

  • 0 min

Share

  • 1

    HCV infection affects over 3% of the global population, with the highest prevalence in Africa, leading to severe liver complications if untreated.

  • 2

    Direct-acting antivirals (DAAs) have revolutionized HCV treatment since 2013, achieving sustained virologic response (SVR) rates above 90%.

  • 3

    In Saudi Arabia, approximately 0.5% of the population is infected with HCV, with 50% of treated patients achieving cure rates using standard therapies.

  • 4

    The study analyzed treatment outcomes of DAAs in HCV patients in Saudi Arabia, providing complete follow-up data for SVR12 and SVR24.

  • 5

    A total of 144 patients were included in the analysis, with no loss to follow-up, ensuring comprehensive data on treatment efficacy.

Original Source(s)

Retrospective Analysis of Direct-Acting Antiviral Treatment Outcomes in Hepatitis C Patients in Saudi Arabia Before and After Therapy

  • by Fatimah Salem Alayidh, Alexander Woodman, Nawaf Yahya Zakary, Rehab Yusuf Al-Ansari, Sharjeel Chaudhry, Amal Omar Alsaadi, Khadijah Ahmad Alharbi, Batool Abdullah Alamri, Shahad Mousa Alhomud, Shahad Hassan Albather, Sarah Abdullah Bataweel, Nouf Ahmed Madkhali, Samira Jamaan Alzahrani, Zarmina Ehtesham

  • February 2, 2026

Related Content

Calcium Intake and Bone Mineral Density in People With HIV and/or Chronic Hepatitis C

Infectious Diseases in People Who Use Drugs Introduction

Human serum-supplemented cell culture conditions improve xenobiotic metabolism in hepatoma cell lines HepG2 and Huh7